Australia markets open in 6 hours 30 minutes

Alpha Tau Medical Ltd. (DRTS)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
2.5700+0.0600 (+2.39%)
As of 12:38PM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 173.10M
Enterprise value 108.48M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)2.22
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.76
52-week change 3-46.60%
S&P500 52-week change 323.49%
52-week high 34.7500
52-week low 32.1500
50-day moving average 32.6687
200-day moving average 33.0726

Share statistics

Avg vol (3-month) 334.51k
Avg vol (10-day) 330.35k
Shares outstanding 569.8M
Implied shares outstanding 669.8M
Float 851.74M
% held by insiders 125.72%
% held by institutions 12.76%
Shares short (30 Apr 2024) 428.85k
Short ratio (30 Apr 2024) 40.6
Short % of float (30 Apr 2024) 40.08%
Short % of shares outstanding (30 Apr 2024) 40.04%
Shares short (prior month 28 Mar 2024) 456.5k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-19.60%
Return on equity (ttm)-30.67%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -34.61M
Net income avi to common (ttm)-29.16M
Diluted EPS (ttm)-0.4000
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)81.79M
Total cash per share (mrq)1.17
Total debt (mrq)13.28M
Total debt/equity (mrq)15.72%
Current ratio (mrq)12.07
Book value per share (mrq)1.21

Cash flow statement

Operating cash flow (ttm)-17.96M
Levered free cash flow (ttm)-19.4M